alfuzosin has been researched along with Hypertrophy in 1 studies
alfuzosin: structure given in first source
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egilmez, T | 1 |
| Pourbagher, MA | 1 |
| Guvel, S | 1 |
| Kilinc, F | 1 |
| Turunc, T | 1 |
| Ozkardes, H | 1 |
1 other study available for alfuzosin and Hypertrophy
| Article | Year |
|---|---|
Effects of selective alpha-1-adrenergic receptor blockers on bladder weight.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Humans; Hypertrophy; Ma | 2006 |